ArticleNature communications2025

Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2.

Hao Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.